A Phase I Study of Immune Checkpoint Inhibition (anti-CTLA4 and anti-PD-L1) in Combination with RadiationTherapy in Patients with Locally Advanced UnresectablePancreatic Cancer
Year: 2020
Type: article
Study design: Clinical Trial
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3108725187
